Acrylamide-reducing yeast technology being commercialised


Monday, 10 December, 2018


Acrylamide-reducing yeast technology being commercialised

Renaissance BioScience’s non-GMO acrylamide-reducing yeast enzyme Acryleast will be available to food and beverage manufacturers from Kerry Taste & Nutrition Europe from next year.

Acryleast is suitable for use in a range food and beverage products, including biscuits, crackers, French fries, potato crisps, coffee, infant food and more, where it is claimed the enzyme will reduce acrylamide by up to 90%. This clean-label, effective and versatile solution has no or minimal changes to manufacturing processes and no impact on flavour, aroma and texture.

This licence agreement is quite timely given new EU acrylamide regulations, which came into effect in April 2018, and California’s Proposition 65, which requires “potentially harmful” warning labels relating to acrylamide (on food and beverage packaging or in food outlets).

Kerry is adding the enzyme to its clean-label product range.

Related News

Gut health research on display

Twenty-three new abstracts looking at advances in gut microbiome research will be presented at...

Macadamia nut innovation challenge

Next month, the second Macadamia Innovation Challenge finals will take place in Byron Bay,...

Avocado seeds may be able to treat inflammation

Avocado seed extracts could be a potential source for novel anti-inflammatory compounds that...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd